-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Epothilone is a natural product that has been isolated from a variety of fungal sources.
It has been found to have potent cytotoxic activity against a wide range of cancer cells, and as a result, it has become an important subject of study in the field of cancer research.
In the chemical industry, there are several synthetic routes that have been developed to produce epothilone for use in cancer treatments.
The first synthetic route to epothilone was developed by Takimoto and co-workers in 1992.
This route involved a seven-step synthesis that began with the synthesis of the B-ring of epothilone.
The synthesis of the B-ring involved the reaction of a phenyl-substituted malonic acid with an oxazole derivative in the presence of a Lewis acid catalyst.
The resulting B-ring was then coupled with an aromatic aldehyde to form the C-ring of epothilone.
The C-ring was then converted into the D-ring through a series of steps, including reduction, nitration, and halogenation.
Finally, the D-ring was condensed with a propionaldehyde derivative to form the complete epothilone structure.
Another synthetic route to epothilone was developed by Kohn and co-workers in 1994.
This route involved a nine-step synthesis that began with the synthesis of an oxazole derivative.
The oxazole derivative was then converted into an N-heterocyclic carbene (NHC) precursor through the reaction with a phosphorylating agent.
The NHC precursor was then used in a sequence of reactions to form the C-ring of epothilone.
The C-ring was then converted into the D-ring through a series of steps, including reduction, nitration, and halogenation.
Finally, the D-ring was condensed with a propionaldehyde derivative to form the complete epothilone structure.
In 1996, a third synthetic route to epothilone was reported by van Uden and co-workers.
This route involved a six-step synthesis that began with the synthesis of the B-ring of epothilone.
The synthesis of the B-ring involved the reaction of a phenyl-substituted malonic acid with an oxazole derivative in the presence of a Lewis acid catalyst.
The resulting B-ring was then coupled with an aromatic aldehyde to form the C-ring of epothilone.
The C-ring was then converted into the D-ring through a series of steps, including reduction, nitration, and halogenation.
Finally, the D-ring was condensed with a propionaldehyde derivative to form the complete epothilone structure.
In the years since these first synthetic routes to epothilone were reported, several other synthetic methods have been developed.
These methods have aimed to improve upon the original routes by increasing the yield and reducing the number of steps required for synthesis.
Some of these methods have also sought to introduce new functional groups into the epothilone structure to enhance its activity against cancer cells.
One example of a modified synthetic route is the method developed by Kurihara and co-workers in 2002.
This method involves the synthesis of the B-ring and C-ring of epothilone through a series of steps, followed by the synthesis of the D-ring through a sequence of reactions involving a halogenated propionaldehyde derivative.
The resulting epothilone derivative is then further processed to introduce a new functional group at the C-13 position.
This method is highly efficient and has been used to synthesize a variety of epothilone analogs with improved cytotoxicity.
Another example of a modified synthetic route is the method developed by Ki